Ompra-20 capsules gastro-resistant

Valsts: Armēnija

Valoda: angļu

Klimata pārmaiņas: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktīvā sastāvdaļa:

omeprazole

Pieejams no:

Medicamen Biotech Ltd.

ATĶ kods:

A02BC01

SNN (starptautisko nepatentēto nosaukumu):

omeprazole

Deva:

20mg

Zāļu forma:

capsules gastro-resistant

Vienības iepakojumā:

(100/10x10/), in strip

Receptes veids:

Prescription

Autorizācija statuss:

Registered

Autorizācija datums:

2015-12-30

Lietošanas instrukcija

Dimension of leaflet: 283x183mm
TIME TO PEAK EFFECT:
Within 2 hours.
DURATION OF ACTION:
Up to 72 hours or more (96 hours required for full restoration
of acid production).
ELIMINATION:
Following single dose oral administration of a buffered solution of
omeprazole, little if any unchanged drug was excreted in urine. The
majority of the
dose (about 77%) was eliminated in urine as at least six metabolites.
The remainder
of the dose was recoverable in feces.
Renal-70 to 77%, No unchanged Omeprazole was detected in urine
Fecal - 18 to 23%
In dialysis - Not readily dialyzable because of extensive protein
binding
THERAPEUTIC INDICATIONS
Treatment of duodenal ulcers
Prevention of relapse of duodenal ulcers
Treatment and Prevention of relapse of gastric ulcers
Treatment of reflux oesophagitis and symptomatic gastro-oesophageal
reflux disease
& Prevention of NSAID-associated gastric and duodenal ulcers
In patients with severe oesophagitis
Long-term management of patients with healed reflux oesophagitis
Treatment of Zollinger-Ellison syndrome
Symptomatic treatment of heartburn and acid regurgitation in
gastro-oesophageal
reflux disease
DOSAGE & ADMINISTRATION
POSOLOGY IN ADULTS
TREATMENT OF DUODENAL ULCERS
20mg once daily, for 2 weeks. Maximum 40mg once daily for 4 weeks.
PREVENTION OF RELAPSE OF DUODENAL ULCERS
10- 20mg once daily. the dose can be increased to 40mg.
TREATMENT AND PREVENTION OF RELAPSE OF GASTRIC ULCERS
20mg once daily for 4 weeks. Maximum 40mg for 8 weeks.
TREATMENT OF REFLUX OESOPHAGITIS AND SYMPTOMATIC GASTRO-OESOPHAGEAL
REFLUX
DISEASE & PREVENTION OF NSAID-ASSOCIATED GASTRIC AND DUODENAL ULCERS
20mg once daily for 4 weeks.
IN PATIENTS WITH SEVERE OESOPHAGITIS
40mg once daily for 8 weeks.
LONG-TERM MANAGEMENT OF PATIENTS WITH HEALED REFLUX OESOPHAGITIS
10mg once daily. If needed, the dose can be increased to Omeprazole
20-40mg once
daily.
TREATMENT OF ZOLLINGER-ELLISON SYNDROME
60mg daily. When dose exceed Omeprazole 80mg daily, the dose should be
divided
and given twice daily.
CHILDREN OVER 1 YEAR OF A